HomeCompareRMD vs SCHW

RMD vs SCHW: Dividend Comparison 2026

RMD yields 1.06% · SCHW yields 1.21%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 SCHW wins by $18.3K in total portfolio value
10 years
RMD
RMD
● Live price
1.06%
Share price
$220.03
Annual div
$2.33
5Y div CAGR
35.9%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$31.7K
Annual income
$3,288.25
Full RMD calculator →
SCHW
SCHW
● Live price
1.21%
Share price
$93.06
Annual div
$1.13
5Y div CAGR
46.7%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$50.0K
Annual income
$11,081.00
Full SCHW calculator →

Portfolio growth — RMD vs SCHW

📍 SCHW pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodRMDSCHW
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, RMD + SCHW cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
RMD pays
SCHW pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

RMD
Annual income on $10K today (after 15% tax)
$90.01/yr
After 10yr DRIP, annual income (after tax)
$2,795.01/yr
SCHW
Annual income on $10K today (after 15% tax)
$103.21/yr
After 10yr DRIP, annual income (after tax)
$9,418.85/yr
At 15% tax rate, SCHW beats the other by $6,623.84/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of RMD + SCHW for your $10,000?

RMD: 50%SCHW: 50%
100% SCHW50/50100% RMD
Portfolio after 10yr
$40.8K
Annual income
$7,184.62/yr
Blended yield
17.59%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on SCHW right now

RMD
Analyst Ratings
16
Buy
14
Hold
5
Sell
Consensus: Buy
Price Target
$295.88
+34.5% upside vs current
Range: $265.00 — $345.00
Altman Z
11.6
Piotroski
7/9
SCHW
Analyst Ratings
29
Buy
18
Hold
3
Sell
Consensus: Buy
Price Target
$122.78
+31.9% upside vs current
Range: $105.00 — $148.00
Altman Z
0.9
Piotroski
9/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

RMD buys
0
SCHW buys
0
No recent congressional trades found for RMD or SCHW in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricRMDSCHW
Forward yield1.06%1.21%
Annual dividend / share$2.33$1.13
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR35.9%46.7%
Portfolio after 10y$31.7K$50.0K
Annual income after 10y$3,288.25$11,081.00
Total dividends collected$10.4K$27.1K
Payment frequencyquarterlyquarterly
SectorHealthcareFinancials
Analyst consensusBuyBuy
Analyst price target$295.88$122.78

Year-by-year: RMD vs SCHW ($10,000, DRIP)

YearRMD PortfolioRMD Income/yrSCHW PortfolioSCHW Income/yrGap
1← crossover$10,844$143.91$10,878$178.13$34.00SCHW
2$11,801$198.21$11,905$265.67$104.00SCHW
3$12,901$273.96$13,137$398.64$236.00SCHW
4$14,185$380.39$14,660$603.10$475.00SCHW
5$15,709$531.20$16,609$922.71$900.00SCHW
6$17,556$747.16$19,205$1,433.24$1.6KSCHW
7$19,845$1,060.53$22,821$2,272.13$3.0KSCHW
8$22,757$1,522.63$28,120$3,701.76$5.4KSCHW
9$26,567$2,217.64$36,343$6,253.72$9.8KSCHW
10$31,715$3,288.25$49,968$11,081.00$18.3KSCHW

RMD vs SCHW: Complete Analysis 2026

RMDHealthcare

ResMed Inc. develops, manufactures, distributes, and markets medical devices and cloud-based software applications for the healthcare markets. The company operates in two segments, Sleep and Respiratory Care, and Software as a Service. It offers various products and solutions for a range of respiratory disorders, including technologies to be applied in medical and consumer products, ventilation devices, diagnostic products, mask systems for use in the hospital and home, headgear and other accessories, dental devices, and cloud-based software informatics solutions to manage patient outcomes, as well as provides customer and business processes. The company also provides AirView, a cloud-based system that enables remote monitoring and changing of patients' device settings; myAir, a personalized therapy management application for patients with sleep apnea that provides support, education, and troubleshooting tools for increased patient engagement and improved compliance; U-Sleep, a compliance monitoring solution that enables home medical equipment (HME)to streamline their sleep programs; connectivity module and propeller solutions; and Propeller portal. It offers out-of-hospital software solution, such as Brightree business management software and service solutions to providers of HME, pharmacy, home infusion, orthotics, and prosthetics services; MatrixCare care management and related ancillary solutions to senior living, skilled nursing, life plan communities, home health, home care, and hospice organizations, as well as related accountable care organizations; and HEALTHCAREfirst that offers electronic health record, software, billing and coding services, and analytics for home health and hospice agencies. The company markets its products primarily to sleep clinics, home healthcare dealers, and hospitals through a network of distributors and direct sales force in approximately 140 countries. ResMed Inc. was founded in 1989 and is headquartered in San Diego, California.

Full RMD Calculator →

SCHWFinancials

The Charles Schwab Corporation, together with its subsidiaries, provides wealth management, securities brokerage, banking, asset management, custody, and financial advisory services. The company operates in two segments, Investor Services and Advisor Services. The Investor Services segment provides retail brokerage, investment advisory, banking and trust, retirement plan, and other corporate brokerage services; equity compensation plan sponsors full-service recordkeeping for stock plans, stock options, restricted stock, performance shares, and stock appreciation rights; and retail investor and mutual fund clearing services, as well as compliance solutions. The Advisor Services segment offers custodial, trading, banking, and support services; and retirement business and corporate brokerage retirement services. This segment provides brokerage accounts with equity and fixed income, margin lending, options, and futures and forex trading; cash management capabilities comprising third-party certificates of deposit; third-party and proprietary mutual funds; plus mutual fund trading and clearing services; and exchange-traded funds (ETFs), including proprietary and third-party ETFs. It also offers advice solutions, such as managed portfolios of proprietary and third-party mutual funds and ETFs, separately managed accounts, customized personal advice for tailored portfolios, and specialized planning and portfolio management. In addition, this segment provides banking products and services, including checking and savings accounts, first lien residential real estate mortgage loans, home equity lines of credit, and pledged asset lines; and trust services comprising trust custody services, personal trust reporting services, and administrative trustee services. As of December 31, 2021, the Company had approximately 400 domestic branch offices in 48 states and the District of Columbia, as well as locations in Puerto Rico, the United Kingdom, Hong Kong, and Singapore. The Charles Schwab Corporation was incorporated in 1971 and is headquartered in Westlake, Texas.

Full SCHW Calculator →
📬

Get this RMD vs SCHW comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

RMD vs SCHDRMD vs JEPIRMD vs ORMD vs KORMD vs MAIN

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.